Product Attributes CAS # : 2381089-83-2 : C221H342N46O68 (AA) : YXQGTFTSDYSILLDKKAQXAFIEYLLEGGPSSGAPPPS (X = Aib) : 4731.33 g/mol PubChem CID : 171390338 : ~6 : LY3437943, G - GLP-1/GIP/GCGR -, RETA, , , : : , , Scientific References BPC-157 | In vitro BPC-157 , | | In vitro BPC 157: , , | | In vitro BPC 157 | In vitro BPC 157 | | In vitro BPC-157:
Wharton et al
Kantor T, et al
Your provider can review your specific thyroid statuswhether you have hypothyroidism, hyperthyroidism, or autoimmune thyroid diseaseand recommend the GLP-1 formulation and concentration that aligns with your metabolic profile
Semaglutide is administered as a weekly injection that you give yourself in the privacy of your home, typically in the stomach area, thigh, or upper arm
Subcutaneous injections deliver Sermorelin into the fatty tissue beneath the skin, allowing the peptide to enter circulation while avoiding the digestive tract